Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003223

President and CEO gave up 60,256 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Blume-Jensen Peter · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-14 Shares withheld for taxes : show line 1 in the form −59,766 $7.92 $473,347 2,362,747 D
2024-11-14 Shares withheld for taxes : show line 2 in the form −490 $7.92 $3,881 316,756 I
Loading xslF345X05/form4.xml…